AU Stocks

1ST.AX stock surges 22% in pre-market trading on ASX today

April 29, 2026
5 min read

Key Points

1ST.AX stock surges 22.2% to A$0.011 in pre-market ASX trading with exceptional 2.07M share volume

1st Group operates digital health platforms including MyHealth1st, PetYeti, and GoBookings across Australia

Company shows strong 76.2% gross margins but negative profitability with -80.3% operating margins

Meyka AI rates 1ST.AX as HOLD with B grade; forecasts A$0.0072 target within one year

1st Group Limited (1ST.AX) is making waves in pre-market trading on the ASX today, with the healthcare services stock climbing 22.2% to A$0.011 per share. The Sydney-based company, which operates MyHealth1st.com.au, PetYeti, and GoBookings platforms, is seeing robust trading activity with 2.07 million shares exchanged so far. This surge reflects renewed investor interest in the healthcare information services sector. The stock’s momentum comes as the company continues to expand its telehealth software and appointment booking services across Australia’s medical and corporate landscape.

1ST.AX Stock Price Movement and Trading Activity

The 1ST.AX stock opened at A$0.011 today, maintaining its session high and low at the same level. Volume has reached 2.07 million shares, significantly outpacing the average daily volume of 678,621 shares by over 3 times. This elevated trading activity signals strong investor participation in the pre-market session.

The stock’s 22.2% gain represents a solid recovery from yesterday’s close of A$0.009. Year-to-date performance shows the same 22.2% increase, though the stock remains well below its 52-week high of A$0.015 set earlier this year. The current price sits above the 50-day moving average of A$0.00917, suggesting positive short-term momentum.

Market Sentiment and Trading Dynamics

Trading Activity

The relative volume ratio of 3.06 indicates exceptional interest compared to historical averages. Pre-market sessions typically see lower participation, making this surge particularly noteworthy for 1ST.AX. The consistent open and high-low prices suggest orderly buying pressure without extreme volatility.

Liquidation Dynamics

With a market cap of A$15.59 million and enterprise value of A$20.20 million, 1ST.AX remains a micro-cap stock. The elevated volume today could indicate institutional or strategic accumulation. The stock’s price-to-sales ratio of 3.49 reflects market expectations for future revenue growth in the healthcare digital services space.

1st Group Limited Business Overview and Sector Position

1st Group Limited operates three core platforms serving Australia’s healthcare ecosystem. MyHealth1st.com.au functions as a health services marketplace connecting patients with providers. PetYeti extends the model into veterinary services, while GoBookings targets corporate and government SaaS solutions. The company also develops proprietary telehealth software and diagnostic devices integrated with medical practice systems.

The Healthcare sector on the ASX has faced headwinds, with an average sector decline of 10.9% over six months. However, 1ST.AX’s focus on digital health infrastructure positions it differently from traditional healthcare providers. The company serves pharmacies, private practices, specialists, vets, hospitals, and government agencies across Australia.

Financial Metrics and Investment Considerations

Key Financial Position

1st Group Limited reports negative earnings per share of -A$0.01 and a negative PE ratio of -1.1, reflecting current unprofitability. The company’s gross profit margin stands at a healthy 76.2%, indicating strong unit economics on its digital platforms. However, operating margins are deeply negative at -80.3%, suggesting high operating costs relative to revenue.

Valuation and Forecasts

Meyka AI rates 1ST.AX with a grade of B, suggesting a HOLD recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects the stock could reach A$0.0072 within one year, implying potential downside from current levels. These grades are not guaranteed and we are not financial advisors. Track 1ST.AX on Meyka for real-time updates and detailed financial analysis.

Final Thoughts

1ST.AX stock’s 22.2% pre-market surge reflects renewed investor interest in Australia’s digital healthcare sector. While the elevated trading volume and positive price action are encouraging, investors should note the company’s negative profitability metrics and challenging operating environment. The stock trades well below its 52-week high, and Meyka AI’s forecast suggests modest upside potential. The healthcare information services industry remains competitive, but 1st Group’s diversified platform approach across medical, veterinary, and corporate markets offers differentiation. Investors should monitor upcoming earnings announcements and platform adoption metrics before making investment decisions. The current momentum may present a trading opportunity, though fundamental challenges persist.

FAQs

Why is 1ST.AX stock up 22% today in pre-market trading?

Elevated volume of 2.07 million shares (3x average) suggests institutional buying interest. The healthcare digital services sector may be attracting renewed investor attention as telehealth adoption continues across Australia.

What does 1st Group Limited do?

1st Group operates MyHealth1st.com.au (health marketplace), PetYeti (veterinary services), and GoBookings (corporate SaaS platform). It also develops telehealth software and diagnostic devices for medical practices.

Is 1ST.AX profitable?

No. The company reports negative EPS of -A$0.01 and negative PE ratio. However, strong gross margins of 76.2% indicate the business model works; operating costs currently exceed revenue.

What is Meyka AI’s price forecast for 1ST.AX?

Meyka AI projects 1ST.AX could reach A$0.0072 within one year, suggesting potential downside from the current A$0.011 price. Forecasts are model-based projections, not performance guarantees.

How does 1ST.AX compare to other healthcare stocks on the ASX?

1ST.AX is a micro-cap healthcare information services stock, distinct from larger peers like CSL and ResMed. Its digital focus offers different risk-return characteristics than traditional healthcare providers.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)